Opiate Detox: What to Expect During Medical Withdrawal

Opiate withdrawal typically begins 8–24 hours after last use (heroin/short-acting opioids) or 36–48 hours (methadone/long-acting). Peak symptoms occur days 2–4. Fentanyl withdrawal may begin faster — within 6–12 hours — due to its short half-life. Medical detox is strongly recommended; withdrawal is rarely fatal but complications are serious without monitoring.

Opiate Withdrawal by Substance: Timelines Are Not the Same

Every competitor page on this topic uses one generic opioid withdrawal timeline. In clinical reality, the timeline depends heavily on which opioid was used, for how long, and at what dose. A protocol designed around a heroin patient is not optimal for a fentanyl patient, and a methadone taper requires an entirely different approach. The four substance-specific timelines below reflect current addiction-medicine practice.

Heroin and short-acting opioid withdrawal (8–24 hrs onset)

Heroin, oxycodone, hydrocodone, and other short-acting opioids produce withdrawal that begins 8 to 24 hours after the last dose, depending on frequency and quantity of use. Early symptoms include anxiety, yawning, runny nose, sweating, and mild muscle aches. By hour 24–48, symptoms escalate: severe bone and joint pain, abdominal cramping, nausea, vomiting, diarrhea, dilated pupils, goose-flesh (hence the phrase "quitting cold turkey"), and intense craving. The acute phase peaks on days 2–3, begins declining by days 4–5, and largely resolves by days 7–10. Buprenorphine induction is standard on day 2 once COWS scores reach 11–13.

Fentanyl withdrawal (6–12 hrs onset — the fastest timeline)

Fentanyl has a shorter plasma half-life than heroin but — paradoxically — often produces withdrawal onset that is faster, more intense, and more difficult to stabilize with standard buprenorphine induction protocols. Onset is typically 6 to 12 hours after last use. Peak severity is reached by 24–36 hours. The acute phase may be shorter than with heroin (5–7 days of acute symptoms for many patients), but precipitated withdrawal during buprenorphine induction is a well-documented risk in fentanyl-using patients because fentanyl stores in fatty tissue and releases back into circulation slowly. Many addiction-medicine protocols now use low-dose or "micro-induction" buprenorphine starts for fentanyl patients, or a short course of full-agonist methadone in inpatient settings before converting to buprenorphine. This is a 2025-accurate clinical reality: patients who used primarily fentanyl should be detoxed with a protocol designed for fentanyl, not one designed for heroin.

Prescription opioid withdrawal (Oxycontin, Vicodin — 12–24 hrs)

Oxycodone, hydrocodone, and similar Schedule II prescription opioids produce a withdrawal profile close to heroin but generally milder and slightly delayed. Onset is typically 12 to 24 hours after the last dose, peak is days 2–3, and acute symptoms resolve in 5–7 days for most patients. Patients who used extended-release formulations (OxyContin ER, fentanyl transdermal patches) experience delayed-onset withdrawal that can begin 24–36 hours after the last dose and produce a longer acute phase of 7–10 days. Co-occurring chronic pain must be addressed as part of detox planning — most residential facilities have protocols for non-opioid pain management during and after detox.

Methadone withdrawal (36–48 hrs — the longest timeline)

Methadone's 24- to 36-hour half-life produces the longest and slowest opioid withdrawal of any substance. Onset is 36 to 48 hours after the last dose, peak severity is days 5–7, and the acute phase can extend 14 to 21 days. Patients transitioning off methadone almost always require inpatient detox because the duration and severity make self-taper impractical and dangerous. Buprenorphine conversion from methadone requires a controlled taper to a dose below 30 mg/day before induction, or a specific washout protocol, to avoid precipitated withdrawal.

The COWS Scale: How Clinicians Measure Withdrawal Severity

The Clinical Opiate Withdrawal Scale is the 11-item clinician-administered tool used in virtually every inpatient detox in the United States. COWS produces an objective score that guides buprenorphine induction timing, supportive medication dosing, and decisions about step-down from detox to the rehab phase.

The 11 items are: resting pulse rate, sweating, restlessness, pupil size, bone or joint aches, runny nose or tearing, gastrointestinal upset, tremor, yawning, anxiety or irritability, and gooseflesh skin. Each item is scored on a short ordinal scale (typically 0–4 or 0–5). The total is interpreted as:

• 5–12: Mild withdrawal — supportive care, comfort medication, monitoring
• 13–24: Moderate withdrawal — buprenorphine induction window opens at COWS ≥11–13
• 25–36: Moderately severe withdrawal — aggressive medication management; peak intensity for most short-acting opioid patients
• 37 and above: Severe withdrawal — escalate medications, consider additional interventions

Nursing staff typically score COWS every 2 to 4 hours during the acute phase. A declining score across 24 hours is the clinical signal that the patient is moving out of acute withdrawal and into the stabilization window.

Withdrawal Symptoms Day-by-Day

For a patient using short-acting opioids (the most common presentation), this is what the week typically looks like inside a medical detox unit:

• Day 1. Onset 6 to 24 hours after last dose. Early anxiety, restlessness, yawning, runny nose, mild muscle aches. COWS typically 8–15. First dose of supportive medications (clonidine for autonomic symptoms, ondansetron for nausea, loperamide for GI, non-opioid analgesics for aches).
• Day 2 (worst day for short-acting opioids). Full syndrome emerges. Severe bone and joint aches, sweating and chills, abdominal cramps, nausea and vomiting, diarrhea, intense craving, anxiety, insomnia. COWS often peaks at 25–36. Buprenorphine induction begins once COWS ≥11–13 (typically day 1 evening or day 2 morning).
• Day 3. Continued peak intensity. GI symptoms often worst on this day. Patient is stabilized on buprenorphine; dose is titrated based on symptom control.
• Day 4. First signs of improvement. Sleep begins to return, GI symptoms ease, muscle aches reduce. COWS declining.
• Day 5. Acute symptoms substantially better. Patient is engaged in initial group programming and behavioral therapy. Peak intensity day for some methadone patients.
• Days 6–10. Acute phase resolves for most short-acting opioid patients. Transition to the residential rehab phase. Buprenorphine continues; long-term MAT planning begins.

Can Opiate Withdrawal Be Fatal?

The direct answer is: rarely. Opioid withdrawal, unlike alcohol or benzodiazepine withdrawal, does not typically cause seizures or delirium that can kill a medically healthy adult. However, it is not safe to conclude that opioid withdrawal is therefore "safe" without medical care. The two clinical realities that make unsupervised detox dangerous are:

• Complications that can be fatal. Severe vomiting and diarrhea cause dehydration and electrolyte derangement that can precipitate cardiac arrhythmias, especially in patients with preexisting heart disease. Aspiration during vomiting, particularly when combined with sedating supportive medications used at home, can be fatal. Pregnant patients are at elevated risk of complications including preterm labor.
• Overdose risk after detox. This is the deadliest complication of completed detox. Opioid tolerance falls dramatically within days of abstinence. A dose the patient tolerated before detox is often fatal after. Relapse immediately following a home detox — when the patient has no access to naloxone and no medical monitoring — is a leading cause of overdose death. Inpatient detox followed directly by residential rehab protects the patient through this window and establishes naltrexone or buprenorphine maintenance before discharge.

What Medical Detox Provides That Home Detox Cannot

Unsupervised detox is strongly discouraged for every opioid patient and especially so for fentanyl users. Medical detox in an inpatient setting provides: continuous vital-sign monitoring, immediate intervention for complications, COWS-guided medication dosing, 24-hour physician and nursing oversight, a controlled environment with no access to substances, immediate transition to the rehab phase, and naloxone and buprenorphine or naltrexone maintenance established before discharge. None of these are available in a home setting. There is no patient profile for whom self-detox from opioids — especially fentanyl — is the medically preferred option.

How Long Until Your Brain Chemistry Recovers

The question patients and families ask most often is: how long until I feel normal again? The honest answer is that full recovery of brain chemistry takes longer than the acute phase of withdrawal, but the trajectory is steadily upward. Key milestones from the neuroimaging and clinical research literature:

• Days 7–14. Acute withdrawal resolves for short-acting opioid patients. Executive function remains impaired. Mood is unstable.
• Days 30–90. Measurable recovery in prefrontal cortex activity. Sleep architecture improves. Executive function (planning, impulse control, working memory) begins to return toward baseline. Anhedonia — the inability to feel pleasure from normal activities — often persists.
• Months 3–6. Craving intensity declines substantially in most patients. Baseline dopamine response to natural rewards partially recovers. Mood stabilizes. This is the window where discontinuation of medication-assisted treatment is most commonly considered and most commonly reversed — many patients do best with longer MAT durations.
• Months 12–18. Baseline dopamine response approaches pre-use levels for most patients. Neuroimaging changes associated with opioid use disorder largely reverse. Post-acute withdrawal symptoms resolve for the majority of patients.

The brain heals on its own timeline. Inpatient detox and residential rehab do not speed up neurobiology — they create the conditions (no access, medical support, behavioral therapy, medication-assisted treatment) under which the patient survives and stays abstinent through the 12–18 month window the brain needs to recover.

Frequently Asked Questions

How long does opioid withdrawal last?

The timeline depends on the substance. Short-acting opioids (heroin, oxycodone, hydrocodone) produce withdrawal that begins 8–24 hours after last use, peaks at days 2–4, and resolves by days 7–10. Fentanyl, despite its short half-life, often produces a more rapid onset (6–12 hours) and a somewhat shorter acute phase. Long-acting opioids (methadone, extended-release formulations) produce delayed-onset withdrawal that begins 36–48 hours after last dose and can persist 14–21 days. Post-acute symptoms — insomnia, anhedonia, craving — can last months.

What are the worst days of withdrawal?

For short-acting opioids, days 2 and 3 are typically the most severe — peak symptoms include muscle and bone aches, gastrointestinal distress, chills and sweating, anxiety, and intense craving. For methadone, peak symptoms often come later, around days 5–7, and persist longer. COWS scores typically peak at 25–36 (moderately severe to severe) during these days and then decline steadily with each 24-hour period.

What is the 7-day rule for opioids?

The "7-day rule" is a clinical heuristic, not a formal protocol — it refers to the approximate length of acute opioid withdrawal for short-acting substances like heroin and oxycodone. For most patients on short-acting opioids, the worst of the acute withdrawal resolves within seven to ten days. Methadone and other long-acting opioids do not follow this timeline; their acute phase can extend 14–21 days. The rule does not apply to post-acute withdrawal syndrome, which can last weeks or months.

How long does brain recovery take after opioids?

Structural and functional brain changes begin reversing within days of last use, but full recovery of the dopaminergic reward system takes 12 to 18 months on average, based on neuroimaging research. Short-term executive function improvements are measurable at 30–90 days; craving intensity typically declines substantially after 3–6 months; and baseline dopamine response to natural rewards generally returns to near-normal in the 12–18 month range. Medication-assisted treatment with buprenorphine or naltrexone during this window protects the brain from relapse while it heals.

Can opiate withdrawal be fatal?

Opioid withdrawal itself is rarely directly fatal — unlike alcohol or benzodiazepine withdrawal, which can cause life-threatening seizures. However, opioid withdrawal is associated with serious and potentially fatal complications: severe dehydration from vomiting and diarrhea, aspiration, electrolyte abnormalities, and — most dangerous — relapse immediately after detox. Relapse after even brief abstinence dramatically lowers opioid tolerance, which is the leading cause of fatal overdose after completed detox. Medical supervision is the standard of care specifically because it prevents these complications.

What is the COWS scale?

The Clinical Opiate Withdrawal Scale is a validated 11-item clinical instrument used to measure withdrawal severity. Each item (resting pulse, sweating, restlessness, pupil size, bone or joint aches, runny nose or tearing, GI upset, tremor, yawning, anxiety or irritability, gooseflesh) is scored; the total score determines severity: 5–12 mild, 13–24 moderate, 25–36 moderately severe, over 36 severe. Clinicians use COWS every few hours during detox to adjust buprenorphine and supportive medication dosing.